Arthrex Eclipse Shoulder Prosthesis System

FDA 510(k) K183194 · Arthrex, Inc.

Substantially Equivalent

510(k) numberK183194

Submission

Device name
Arthrex Eclipse Shoulder Prosthesis System
Applicant
Arthrex, Inc.
Naples, FL, US
Received
November 19, 2018
Decision date
July 26, 2019
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QHQ – Total Shoulder Arthroplasty System
Device class
Class II (moderate risk)
Regulation
21 CFR 888.3660
Specialty
Orthopedic
Implant
Yes

To treat pain and lack of function in the shoulder.

More from Arthrex, Inc.

510(k)DeviceDecision
K262451Arthrex DynaNite StaplesJDR · Traditional 09/01/2026SE
K262357Arthrex Bioabsorbable PushLock Suture AnchorsMAI · Special 08/07/2026SE
K260624Arthrex Radial Head Replacement SystemKWI · Traditional 07/30/2026SE
K260018Arthrex FiberButtonMBI · Traditional 06/26/2026SE
K260809Arthrex Sterile VAL and VAL KreuLock™ Compression Screw SystemHWC · Traditional 06/25/2026SE
K253931Arthrex Bioabsorbable PushLock Suture AnchorsMAI · Traditional 05/28/2026SE
K254215Arthrex Beaming SystemHWC · Traditional 05/08/2026SE
K260561Arthrex FiberTak Suture AnchorMBI · Special 03/20/2026SE
K252016Arthrex Humeral NailsHSB · Traditional 03/20/2026SE
K260405FiberTape ButtonMBI · Special 03/09/2026SE

Questions and answers

When was Arthrex Eclipse Shoulder Prosthesis System cleared by the FDA?

Arthrex Eclipse Shoulder Prosthesis System (K183194) received a 510(k) decision of Substantially Equivalent on July 26, 2019, 249 days after the submission was received.

What is the product code of K183194?

The FDA product code is QHQ – Total Shoulder Arthroplasty System, a Class II (moderate risk) device regulated under 21 CFR 888.3660.